Posttransplant bone disease: evidence for a high bone resorption state

Area of Science:

• Nephrology
• Endocrinology
• Orthopedics

Background:

• Bone loss is a significant complication following renal transplantation.
• Conflicting data exist regarding bone loss beyond the first post-transplant year and its correlation with bone turnover.
• The prevalence and predictors of osteoporosis in long-term renal transplant recipients with preserved renal function remain unclear.

Purpose of the Study:

• To determine the prevalence of osteoporosis in long-term renal transplant recipients (> 1 year) with preserved renal function.
• To investigate the correlation between bone mineral density (BMD) and markers of bone turnover and calcium metabolism.
• To identify predictors of bone mass in this patient population.

Main Methods:

• Cross-sectional study of 69 long-term renal transplant recipients with preserved renal function.
• Bone mineral density (BMD) measured at hip, spine, and wrist using DEXA.
• Assessed bone formation (serum osteocalcin) and resorption (urinary pyridinoline [PYD] and deoxypyridinoline [DPD]), along with calcium metabolism parameters.

Main Results:

• Osteoporosis diagnosed in 44% and osteopenia in 44% of patients.
• Elevated intact parathyroid hormone (iPTH) in 81% and elevated urinary PYD or DPD in 73% of patients.
• Urinary PYD was the strongest predictor of bone mass in a multivariate regression model.

Conclusions:

• Osteoporosis is highly prevalent in long-term renal transplant recipients.
• Elevated bone resorption rates significantly contribute to bone loss in these patients.
• Urinary PYD is a key indicator for predicting bone mass in renal transplant recipients.